Skip left side navigation and go to content NHLBI AND THE RECOVERY ACT
featured scientist featured scientist featured scientist featured scientist

Funding and Policies: The NHLBI and the Recovery Act

The NHLBI's funding plan strikes an important balance between increasing the number of investigator-initiated research grants and commitment to signature projects through the following mechanisms:

All Recovery Act awards will come with special reporting requirements that demonstrate how the project meets the objectives of the Recovery Act. (See the ‘overview’ section for fund plan allocations.)

Note: The NHLBI can fund only an extremely small number of contracts and does not plan to fund Competitive Revision Awards (competitive supplements).

NHLBI Research Grants: Expansion of FY 2008 and FY 2009 paylines*
The following proposals were funded by the NHLBI:

  • Highly meritorious investigator-initiated (R01) applications and similar mechanisms that ranked from the 15.1 through the 25 percentile and are capable of making significant advances with a two-year grant.
  • Early-stage investigators up to the 35th percentile. The first two years are being paid for with Recovery Act funds. The remaining years will be funded using usual appropriated funds.
  • New investigator-initiated (R01) applications that ranked from the 20.1 to the 30.0 percentile and are capable of making significant advances in two years.

*Note: Eligible applicants were notified by the NHLBI.

NHLBI Participation in NIH-Wide Recovery Act RFAs

NHLBI Participation in NIH-Wide Recovery Act RFAs (CLOSED)



Last Updated: November 20, 2009


Important Links
Information from the White House and President Obama

Recovery Information from Health and Human Services

NIH's Role in ARRA

NIH's Recovery Site

Inspector General (IG)


E-Newsletter Sign-Up
Interested in Recovery Act
information? Join the NHLBI Research and Policy Update listserv to receive The NHLBI’s Recovery Act News e-newsletter and other updates. Join the listserv.

Share Your Recovery Act Story
Please send us an e-mail.